Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Registry sponsor category
Industry
- Other names
- Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
- Company name
- Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
- Organisation type
- Industry
- Registry sponsor category
- Industry
- Publicly traded (proxy)
- No
- Listing at source
- Listed
Related records
Trials (51)
- A Bioequivalence and Efficacy Study of MB-102 (Relmapirazin) in Chinese Participants
- A Drug-Drug Interaction (DDI) Study of HDM1002 With Repaglinide, Atorvastatin, Digoxin and Rosuvastatin in Healthy Subjects and Overweight Subjects.
- A Drug-Drug Interaction (DDI) Study of HDM1002 With Rifampicin and Itraconazole in Healthy Subjects
- A Drug-Drug Interaction Study of HDM1002 and Metformin, Empagliflozin, Midazolam, Valsartan, and Warfarin
- A Pharmacokinetic Study of HDM1005 Injection in Participants With Impaired Renal Function and Healthy Participants
- A Phase 1 Study of HDM2017 in Advanced Solid Tumors
- A Phase 3 Study to Evaluate Efficacy and Safety of HDM1002 Tablets in Adults With Type 2 Diabetes Mellitus
- A Phase Ib/II Study of HDM2017 in Combination With Standard of Care in Advanced Colorectal Cancer
- A Phase III Trial To Evaluate The Efficacy And Safety Of MC2-01 Cream Compared To CAL/BDP Gel and Vehicle In Plaque Psoriasis Subjects
- A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Study to Evaluate the Efficacy and Safety of HDM1005 Injection in Subjects With Obstructive Sleep Apnea (OSA) and Obesity Not Receiving Positive Airway Pressure (PAP) Therapy
- A Relative Bioavailability and Food Effect Study of HDM1002 in Healthy Subjects
- A Single-arm Clinical Trial of IMGN853 in Chinese Adult Patients With Platinum-resistant, Epithelial Ovarian Cancer
- A Study of HDM1002 in Subjects With And Without Varying Degrees Of Hepatic Impairement
- A Study of HDM1002 Tablets on Cardiac Repolarization in Healthy Subjects
- A Study of HDM1005 in Participants With T2DM Not Controlled With Diet/Exercise or Metformin
- A Study of HDM1005 in Participants With T2DM Not Controlled With Metformin Alone or in Combination With a Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitor
- A Study of HDM1005 in Participants With Type 2 Diabetes Not Controlled With Diet and Exercise Alone
- A Study of HDM2005 in Combination With Standard of Care in Patients With Diffuse Large B-Cell Lymphoma
- A Study of HDM2005 in Patients With Advanced Solid Tumor
- A Study of HDM2005 in Patients With Relapsed/Refractory B-cell Lymphoma and Advanced Solid Tumor